Apiam Scheme Becomes Effective as ASX Trading Suspension and Takeover Timetable Locked In

Apiam Animal Health Ltd. ( (AU:AHX) ) has shared an announcement.

Apiam Animal Health Limited has confirmed that the scheme of arrangement under which entities controlled by Adamantem Capital Fund II will acquire all Apiam shares is now legally effective, following approval by the Supreme Court of New South Wales and lodgment of court orders with ASIC. As a result, Apiam’s shares are expected to be suspended from trading on the ASX at the close of trade on 6 February 2026, with a detailed timetable set for special dividend key dates, the scheme record date on 18 February 2026, and implementation of the transaction on 23 February 2026, marking Apiam’s transition from a listed to privately owned company and crystallising outcomes for its shareholders.

The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.

More about Apiam Animal Health Ltd.

Apiam Animal Health Limited is one of Australia’s leading rural veterinary businesses, operating more than 80 clinic sites and ancillary locations across regional and peri‑urban areas nationwide. Supported by over 1,000 staff, including a large team of experienced veterinarians, the company focuses on mixed and production animal veterinary services and allied animal health offerings, with an emphasis on high-standard care for clients, animals and local communities.

Average Trading Volume: 264,128

Technical Sentiment Signal: Buy

Current Market Cap: A$160.1M

For an in-depth examination of AHX stock, go to TipRanks’ Overview page.